Depressive symptoms in youth with refractory epilepsy: Exploration of seizure, sociodemographic and cognitive factors
- PMID: 40743949
- DOI: 10.1016/j.yebeh.2025.110608
Depressive symptoms in youth with refractory epilepsy: Exploration of seizure, sociodemographic and cognitive factors
Abstract
Introduction: Rates of depressive symptoms in children and youth with epilepsy (CYE) vary among studies, ranging from 12 to 41%. The current study examined depressive symptoms in a large, multi-site sample of CYE who completed measures of emotional and behavioral functioning as part of a pre-surgical neuropsychological evaluation.
Methods: CYE ranged in age from 5 to 18 years old, had refractory epilepsy (n = 416), and underwent neuropsychological assessment, including standardized assessment of intellectual (IQ), emotional, and behavioral functioning using caregiver-proxy. Sociodemographic (e.g., age, biological sex, race/ethnicity, insurance status, distance from hospital) and epilepsy-specific characteristics e.g., seizure type, epilepsy duration, frequency, foci, number of anti-seizure medications [ASM], and MRI findings) were also examined.
Results: Elevated levels (i.e., at-risk or clinically significant threshold) of depressive symptoms were reported in 28.9 % of CYE. Youth with temporal lobe epilepsy (TLE; 18.9 %) had significantly higher rates of depressive symptoms compared to youth with extratemporal epilepsy (11.7 %; OR = 1.73, 95 % CI [1.10, 2.73]; χ2 (2) = 7.08, p = 0.029). All other sociodemographic and epilepsy-specific variables were unrelated to levels of depressive symptoms. There was no difference in level of depressive symptoms for CYE with IQ below 70 despite being more likely to be in a minority racial/ethnic group, having public insurance, and experiencing more frequent seizures.
Conclusions: CYE are at risk of comorbid depressive symptoms, especially if they have TLE. However, other seizure and sociodemographic variables did not increase risk or resilience. Depression screening during routine epilepsy care is indicated, including for those CYE with low IQ.
Keywords: Depression; Epilepsy; IQ; Pediatric; Pre-Surgical.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2. Cochrane Database Syst Rev. 2022. PMID: 35844168 Free PMC article.
-
Treatments for seizures in catamenial (menstrual-related) epilepsy.Cochrane Database Syst Rev. 2021 Sep 16;9(9):CD013225. doi: 10.1002/14651858.CD013225.pub3. Cochrane Database Syst Rev. 2021. PMID: 34528245 Free PMC article.
-
Surgery for epilepsy.Cochrane Database Syst Rev. 2015 Jul 1;(7):CD010541. doi: 10.1002/14651858.CD010541.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2019 Jun 25;6:CD010541. doi: 10.1002/14651858.CD010541.pub3. PMID: 26130264 Updated.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Yoga for epilepsy.Cochrane Database Syst Rev. 2017 Oct 5;10(10):CD001524. doi: 10.1002/14651858.CD001524.pub3. Cochrane Database Syst Rev. 2017. PMID: 28982217 Free PMC article.
LinkOut - more resources
Full Text Sources